Abstracts Archive - Page 734 of 2425 - ACR Meeting Abstracts

Abstract Number: 1602 • ACR Convergence 2020
Assessing the Psychometric Properties of a Measure of Patient Empowerment with Patients with Arthritis
Erin Knight-Zhang¹, Kathleen Carluzzo¹, Karen Schifferdecker¹, Emily Creek², Rebecca Butcher¹ and Guy Eakin², ¹Dartmouth College, Lebanon, NH, ²Arthritis Foundation, Atlanta, GA
Background/Purpose: The Health Care Empowerment Questionnaire (HCEQ) was developed for use in a general sample of patients to measure individual empowerment in health care and…
Abstract Number: 1601 • ACR Convergence 2020
Pilot Testing Supports Utility of a Point-of-Care Dashboard to Enhance Patient and Clinician Partnerships in the Management of RA
Stephanie Mathew¹, John Mecchella¹, Lisa Johnson², Aricca Van Citters², Stacy Courtnay³, Jennifer Marden⁴, Jabeen Ahmad², Guy Eakin⁵, Eugene Nelson², Salahuddin Kazi⁶ and Scott Pompa¹, ¹Dartmouth-Hitchcock Medical Center, Lebanon, NH, ²The Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, NH, ³Patient Partner, Atlanta, GA, ⁴Dartmouth-Hitchcock Medical Center; Patient Partner, Lebanon, NH, ⁵Arthritis Foundation, Atlanta, GA, ⁶Veterans Affairs North Texas Healthcare System / UT Southwestern Medical Center, Dallas, TX
Background/Purpose: Increasing evidence exists that health outcomes are improved when people living with a chronic condition partner with their clinicians to coproduce their care based…
Abstract Number: 1607 • ACR Convergence 2020
Effectiveness of Dietary Counseling on Gout Management and Risk Factors for Metabolic Syndrome in Gout Patients
Juliana Chang¹, Jonathan Tsui² and Maida Wong³, ¹Division of Rheumatology, Department of Medicine, University of California Irvine, Irvine, CA, ²Geisinger Medical Center, Danville, PA, ³Division of Rheumatology, Department of Medicine, VA Long Beach Healthcare System, Long Beach, CA
Background/Purpose: Gout is the most prevalent inflammatory arthritis globally. Despite treatment advances, the prevalence of gout has continued to increase over the last several decades.…
Abstract Number: 1609 • ACR Convergence 2020
The Accuracy of Administrative Health Data for Identifying Patients with Rheumatoid Arthritis: A Validation Study Using Medical Records in Western Australia
Khalid Almutairi¹, Johannes Nossent¹, David Preen¹, Helen Keen¹, Katrina Rogers² and Charles Inderjeeth¹, ¹The University of Western Australia, Perth, Western Australia, Australia, ²Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
Background/Purpose: The use of large administrative health datasets is increasingly important in Rheumatology for disease trends and outcome research. We established the West Australian Rheumatic…
Abstract Number: 1604 • ACR Convergence 2020
The Impact of the COVID-19 Pandemic on Rheumatology Practice: A Study in 15 Arab Countries
Nelly Ziade¹, Ihsane Hmamouchi², Lina El Kibbi³, Nizar Abdulateef⁴, Hussein Halabi⁵, Fatemah Abutiban⁶, Wafa Hamdi⁷, Manal el Rakawi⁸, Mervat Eissa⁹ and Basel Masri¹⁰, ¹Saint-Joseph University, Beirut, Lebanon, Beirut, Lebanon, ²Temara Hospital, Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco, Rabat, Morocco, ³Specialized Medical Center, Riyadh, Saudi Arabia, Riyadh, Saudi Arabia, ⁴Rheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Iraq, Baghdad, Iraq, ⁵King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia, Jeddah, Saudi Arabia, ⁶Rheumatology Unit, Department of Medicine, Jaber Alahmed Alsabah hospital, State of Kuwait, Jahra, Kuwait, ⁷Department of Rheumatology, Kassab Institute of orthopedics, UR17SP04, Faculty of Medicine of Tunis, Tunis El Manar University, Tunisia, Tunis, Tunisia, ⁸Departement of Rheumatology, Douera Hospital, Faculty of Medicine, Saad Dahlab, Blida, Algeria, Blida, Algeria, ⁹Rheumatology Department, Cairo University, Cairo, Egypt, Cairo, Egypt, ¹⁰Jordan Hospital, Amman, Jordan, Amman, Jordan
Background/Purpose: To date, information about the impact of the Coronavirus Disease (COVID-19) pandemic on rheumatology practice and on rheumatologists is limited.The primary objective of the…
Abstract Number: 1599 • ACR Convergence 2020
Workflows for Collecting and Using Patient-reported Outcomes Across Rheumatology Practices
Meera Subash¹, Kimberly DeQuattro², Sonam Choden³, Lucy Liu⁴, Puneet Bajaj⁵, Christie Bartels⁶, Jennifer Barton⁷, Bonnie Bermas⁸, Maria (Maio) Danila⁹, Julianna Desmarais¹⁰, Christina Downey¹¹, Sancia Ferguson¹², Sarah Goglin¹³, Margaret Guthrie¹⁴, Irum Jan¹⁵, Nikila Kumar¹⁶, Shraddha Prakash¹⁷, Kimberly Reiter¹⁸, Elizabeth Wahl¹⁹, Elena Weinstein²⁰, JoAnn Zell²¹, Gabriela Schmajuk²² and Jinoos Yazdany², ¹University of California, San Francisco, San Francisco, CA, ²UCSF, San Francisco, CA, ³University of California, San Francisco, San Francisco, ⁴Kaiser Permanente, Oakland, CA, ⁵UT Southwestern, Dallas, TX, ⁶University of Wisconsin School of Medicine and Public Health, Department of Medicine, Division of Rheumatology, Madison, WI, ⁷VAPORHCS/OHSU, Portland, OR, ⁸UTSouthwestern.edu, Dallas, TX, ⁹University of Alabama at Birmingham (UAB), Birmingham, AL, ¹⁰Oregon Health & Science University, Portland, OR, ¹¹Loma Linda University Medical Center, Redlands, CA, ¹²University of Wisconsin-Madison School of Medicine and Public Health, Department of Medicine, Division of Rheumatology, Oakland, CA, ¹³University of California San Francisco, Burlingame, CA, ¹⁴University of Alabama at Birmingham, DIv. of Clinical immunology & Rheum., Birmingham, AL, ¹⁵VA Albuquerque, Albuquerque, ¹⁶Arizona Arthritis & Rheumatology Associates, P.C., San Jose, CA, ¹⁷Oakcare Medical Group, Pleasanton, CA, ¹⁸Albuquerque VA Medical Center, Albuquerque, NM, ¹⁹VA Puget Sound Healthcare System, Seattle, WA, ²⁰University of Colorado, Englewood, CO, ²¹University of Colorado, Denver, CO, ²²University of California, San Francisco, Atherton, CA
Background/Purpose: The use of patient reported outcomes (PROs) during rheumatology visits may facilitate shared decision making and encourage patients to share their health goals. However,…
Abstract Number: 1612 • ACR Convergence 2020
Assessing Patient Self-Reported Transition Readiness in a Large Pediatric Rheumatology Center
Alexander Alexander¹, Mary Robichaux², Priyanka Moolchandani¹, Cristina Saez¹, Ariel Coleman³, JaLeen Rogers³, Danielle Guffey¹, Anne Dykes³, Miriah Gillispie-Taylor¹ and Tiphanie Vogel⁴, ¹Baylor College of Medicine, Houston, ²Baylor College of Medicine, Houston, TX, ³Texas Children's Hospital, Houston, ⁴Baylor College of Medicine/Texas Children's Hospital, Houston, TX
Background/Purpose: Pediatric rheumatology patients need effective transition from pediatric to adult providers. Texas Children’s Hospital (TCH) rheumatology clinic providers have developed a transition pathway, the…
Abstract Number: 1615 • ACR Convergence 2020
Assessing Preparation for Care Transition Among Adolescents with Rheumatologic Disease: A Quality Assessment with Patient Survey
Jordan Roberts¹, Olha Halyabar², Carter Petty³ and Mary Beth Son¹, ¹Boston Children's Hospital, Boston, MA, ²Children's Hospital/Boston Medical Center, Boston, MA, ³Boston Childrens Hospital, Institutional Centers for Clinical and Translational Research, Boston, MA
Background/Purpose: Despite the risk for poor outcomes and gaps in care in the transition from pediatric to adult care, most pediatric rheumatology centers lack formal…
Abstract Number: 1616 • ACR Convergence 2020
Systematic Review of Effectiveness Outcomes Reported in Rheumatology Transition Literature
Heather Bannerman¹, Karen Beattie¹, Avanti Patel², Milica Tanic², Michelle Batthish³ and Mark Matsos², ¹McMaster University, Hamilton, ON, Canada, ²McMaster University, Hamilton, Canada, ³McMaster Children's Hospital, Hamilton, ON, Canada
Background/Purpose: In young patients with rheumatologic disease, transition from pediatric to adult care is a complex process. Poor transitional care leads to health deterioration, loss…
Abstract Number: 1611 • ACR Convergence 2020
Documentation of Pregnancy Counseling in SSA-Positive Patients of Childbearing Potential: A Cross-Sectional Study
Heinrich-Karl Greenblatt¹ and Elena Weinstein¹, ¹University of Colorado School of Medicine, Aurora, CO
Background/Purpose: Systemic lupus erythematosus (SLE) and primary Sjogren's Syndrome (SS) are highly associated with anti-SSA (anti-Ro) seropositivity. Anti-SSA autoantibodies may cross the placenta, causing a…
Abstract Number: 1622 • ACR Convergence 2020
Determining the Zoster Vaccination Rate Among Veterans on Chronic Immunosuppressive Therapy at the Southeast Louisiana Veterans Healthcare System – a Quality Indicator
Hannah Kenninger¹, Rachel Dayno¹, Nkechinyere Emejuaiwe², Ileannette Robledo-Vega³, Whitney Bembry¹, Myriam Guevara⁴ and Soham Mahato⁵, ¹Tulane University School of Medicine, New Orleans, LA, ²Southeast Louisiana Veterans Healthcare System, New Orlenas, LA, ³Louisiana State University Health Sciences Center, New Orlenas, LA, ⁴Lousiana State University Health Sciences Center, New Orleans, LA, ⁵LSUHSC School of Public Health, New Orleans, LA
Background/Purpose: Herpes Zoster (HZ) causes an infection commonly known as shingles. Patients with HZ are at increased risk for post-herpetic neuralgia, which is painful for…
Abstract Number: 1619 • ACR Convergence 2020
Immunoglobulin G Subclass Ordering Patterns for IgG4-Related Disease at an Academic Medical Center
Lena Eder¹ and David Leverenz², ¹Duke University Hospital, Chapel Hill, NC, ²Duke University, DURHAM, NC
Background/Purpose: We have noticed an increasing number of serum IgG4 levels ordered over the last several years at our institution. This study was performed to…
Abstract Number: 1614 • ACR Convergence 2020
Use of a Best Practice Alert to Encourage Transition Planning and Readiness
Bernard Danna¹, Monique Maher¹, Marietta DeGuzman², Andrea Ramirez¹, Eyal Muscal², Amanda Brown², Martha Curry², Maria Pereira², M. Brad Nelson², Pooja Patel², Ugo Awa², LeeGee Huang³, Blanca Sanchez-Fournier³, JaLeen Rogers³, Ariel Coleman³, Anne Dykes³, Miriah Gillispie-Taylor² and Tiphanie Vogel⁴, ¹Baylor College of Medicine, Houston, TX, ²Baylor College of Medicine, Houston, ³Texas Children's Hospital, Houston, ⁴Baylor College of Medicine/Texas Children's Hospital, Houston, TX
Background/Purpose: Transitioning children with chronic diseases from pediatric to adult care can be challenging. Patients are faced with the emotional shock of entering a new…
Abstract Number: 1506 • ACR Convergence 2020
Correction of Sjögren’s Syndrome Fluid Secretion Deficits in Salivary Gland Acinar Cells by Aquaporin-1 Gene Transfer
Paola Perez¹, Blake Warner², Sandra Wainer¹, Youngmi Ji¹, Thomas Pranzatelli¹ and Jay Chiorini¹, ¹Nidcr, National Institute of Health, Bethesda, MD, ²National Institute of Dental and Craniofacial Research, Bethesda
Background/Purpose: The hallmark clinical complaints in Sjögren’s syndrome (SS) are dry mouth and dry eyes related to salivary and lacrimal glands dysfunction. Reduced salivation reflects…
Abstract Number: 1381 • ACR Convergence 2020
Real-World Mono-, Double and Triple Combination Treatment Patterns with Macitentan in Patients with Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (PAH-CTD): Evidence from the Combined OPUS/OrPHeUS Dataset
Matthew Lammi¹, Kelly Chin², Nick H. Kim³, Vallerie McLaughlin⁴, Roham Zamanian⁵, Megan Flynn⁶, Sandrine Leroy⁷, Rose Ong⁷, Graham Wetherill⁷ and Richard Channick⁸, ¹Lousiana State University Health Sciences Center, New Orleans, LA, ²UT Southwestern Medical Center, Dallas, TX, ³University of California San Diego, La Jolla, CA, ⁴University of Michigan, Ann Arbor, MI, ⁵Stanford University School of Medicine, Stanford, CA, ⁶Actelion Pharmaceuticals US, Inc., South San Francisco, CA, ⁷Actelion Pharmaceuticals Ltd, Allschwil, Switzerland, ⁸University of California Los Angeles, Los Angeles
Background/Purpose: Patients with PAH-CTD have a worse prognosis than patients with most other PAH etiologies. The OPsumit® USers (OPUS) Registry and OPsumit® Historical USers (OrPHeUS)…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].